LEILA BARBOSA: Open Payments
NPI 1720525744 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 23 payments from 14 companies in 2025. Trend: 2023 $117 · 2024 $749 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 3 | $72 |
| PFIZER INC. | 4 | $71 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| Cycle Pharmaceuticals Inc | 2 | $39 |
| Neurelis, Inc. | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| ABBVIE INC. | 1 | $30 |
| SK Life Science, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $22 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
Products named: AUSTEDO XR, ZAVZPRET, SKYCLARYS, REXULTI, Tascenso ODT, VALTOCO, KESIMPTA, QULIPTA.
Industry payments across MA — which companies pay providers there.
